NCT04124354

Brief Summary

Purpose: The investigators propose a 20-participant randomized 2-arm parallel trial with a delayed-intervention control examining how 8 weeks of moderate-intensity walking exercise alters the gut microbiome, short chain fatty acid (SCFA)-producing taxa, and the cardiometabolic profile and body weight of individuals who are overweight or obese and have prediabetes (PreD). Aim 1: Examine and compare exercise-related shifts in the gut microbiome of individuals with PreD. Aim 2: Examine and compare exercise-related changes in SCFA-producing taxa. Exploratory Aim: Examine what percentage of the exercise-related changes observed in participants' gut microbiome and SCFA-producing taxa mediate changes in their cardiometabolic profile and body weight.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 11, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

February 10, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

July 13, 2021

Status Verified

July 1, 2021

Enrollment Period

7 months

First QC Date

October 10, 2019

Last Update Submit

July 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Shannon Index (Alpha-Diversity) as Reflected in Change in Operational Taxonomic Units

    Alpha diversity is the mean species diversity of a local site, which, in this study, is the fecal sample provided by participants used as a proxy for sampling the gut microbiome. The Shannon Index is based on the weighted geometric mean of the proportional abundances of the types of microbes. Change in alpha diversity will be reported as change in operational taxonomic units (OTUs).

    Baseline, 8 weeks

Secondary Outcomes (11)

  • Change in Plasma LDL Concentrations

    Baseline, 8 weeks

  • Change in Plasma HDL Concentrations

    Baseline, 8 weeks

  • Change in Plasma Total Cholesterol Concentrations

    Baseline, 8 weeks

  • Change in Plasma Insulin Concentrations

    Baseline, 8 weeks

  • Change in Plasma Glucose Concentrations

    Baseline, 8 weeks

  • +6 more secondary outcomes

Study Arms (2)

Immediate Experimental Group

EXPERIMENTAL

Participants will immediately begin an experimental supervised moderate-intensity treadmill walking intervention program.

Behavioral: Physical Activity

Delayed Intervention Control Group

NO INTERVENTION

Participants will be asked to maintain their usual physical activity during the initial 8-week intervention period but will undergo all data collection procedures. Following the initial intervention period, these participants will be given the option to complete the 8-week intervention, with identical data collection procedures employed.

Interventions

Participants will attend 3 treadmill walking sessions/week for 8 weeks (24 total)-exercising at 60-75% of their heart rate (HR) reserve monitored using Polar FT1 HR monitors. All walking sessions will take place using treadmills within the West Bank Office Building on the UMN-Twin Cities campus. Each walking session will be 30 min long during intervention weeks 1-4 and 45 min each during weeks 5-8. This exercise dose is equivalent to that employed in the only two human studies of exercise and the gut microbiome in addition to the dosage observed necessary to yield meaningful cardiometabolic changes. After the 4th- and 8th-weeks of the intervention, participants in both study groups will again undergo outcome assessments

Immediate Experimental Group

Eligibility Criteria

Age30 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Classified as overweight or obese with BMI 25.0-39.9 kg/m2
  • Diagnosis of prediabetes as classified by a fasted blood glucose of 100 - 125 mg/dL, 2-hour oral glucose tolerance test of 140 - 199 mg/dL, or HbA1C level of 5.7% - 6.5%
  • Currently engaged in \< 150 minutes/week of physical activity-confirmed via the Modifiable Activity Questionnaire

You may not qualify if:

  • Individuals with contraindications to exercise participation as assessed by the Physical Activity Readiness Questionnaire
  • Self-reported physical/mental disabilities or gastrointestinal conditions
  • Antibiotic usage within the last 45 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Epidemiology Clinical Research Center

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Prediabetic State

Interventions

Exercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 11, 2019

Study Start

February 10, 2020

Primary Completion

August 31, 2020

Study Completion

August 31, 2020

Last Updated

July 13, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations